trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Pregnant women in their third trimester are at higher risk of vulvovaginal candidiasis due to increased estrogen levels in the vaginal mucosa.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that pregnant women in their third trimester are at higher risk of vulvovaginal candidiasis due to increased estrogen levels in the vaginal mucosa?

Yes. Pregnant women experience heightened susceptibility to vulvovaginal candidiasis, largely driven by pregnancy-associated hormonal shifts and elevated estrogen levels that alter the vaginal microenvironment.

Verdict: SUPPORTED · 3 sources for, 0 against · Last checked

The analysis

The claim is specific and empirical, addressing the physiological link between pregnancy, elevated estrogen, and vulvovaginal candidiasis risk. Retrieved papers such as [3], [9], and [10] explicitly discuss hormonal fluctuations and estrogen activity as key drivers or risk factors for VVC susceptibility during pregnancy. Therefore, the evidence strongly supports the claim.

Evidence for · 3
State-of-the-Art Review: Managing Vulvovaginal Candidiasis.
2026
Identifies hormonal changes as a primary contributing factor to the high prevalence of vulvovaginal candidiasis.
Get citation
R, R., JD, S., N, S., F, D. S., A, C., P, V., M, C., A, W., & E, R. (2026). State-of-the-Art Review: Managing Vulvovaginal Candidiasis.. doi.org. https://doi.org/10.1093/cid/ciaf673

See more details
More for · 2
Stage-specific vaginal microbial alterations in pregnancy-associated vulvovaginal candidiasis.
2025
Investigates pregnancy-associated vulvovaginal candidiasis across gestational stages, acknowledging its unique clinical challenges and prevalence during pregnancy.
Get citation
Z, L., Y, Z., X, L., S, Z., Q, G., C, W., & L, M. (2025). Stage-specific vaginal microbial alterations in pregnancy-associated vulvovaginal candidiasis.. doi.org. https://doi.org/10.1128/spectrum.02144-25

An IL-1, IL-17, and IL-22 cytokine circuit controls vulvovaginal candidiasis independently of estrogen.
2026
Discusses the established paradigm linking estrogen activity directly to VVC susceptibility, while exploring overlapping immune mechanisms.
Get citation
BM, C., ME, C., MR, K., AK, V., AJ, W., J, M., SP, V., TC, T., FEY, A., NO, P., I, D., H, Z., E, J., BM, P., & SL, G. (2026). An IL-1, IL-17, and IL-22 cytokine circuit controls vulvovaginal candidiasis independently of estrogen.. doi.org. https://doi.org/10.1371/journal.ppat.1014202

What does the evidence say?

The claim is specific and empirical, addressing the physiological link between pregnancy, elevated estrogen, and vulvovaginal candidiasis risk. Retrieved papers such as [3], [9], and [10] explicitly discuss hormonal fluctuations and estrogen activity as key drivers or risk factors for VVC susceptibility during pregnancy. Therefore, the evidence strongly supports the claim.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work